Simulations Plus Inc. (SLP:NASD)の戦略的SWOTと財務分析

Report Overview

Report Summary

Simulations Plus Inc. Strategic SWOT Analysis and Financial Insights – A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of Simulations Plus Inc.’s business operations. It provides a detailed analysis of the company’s financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company’s performance.

The report begins with in-depth information about Simulations Plus Inc. including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company’s key attributes.

Next, the report assesses Simulations Plus Inc.’s strategic standing through various analyses. The ESG spotlight evaluates the company’s environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company’s internal strengths and weaknesses, as well as external opportunities and threats. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of Simulations Plus Inc.’s overall strategic standing and supports informed decision-making and strategic planning.

The report also covers Simulations Plus Inc.’s financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares Simulations Plus Inc.’s financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors’ operations.

Finally, the report includes recent news and deal activities undertaken by Simulations Plus Inc. enhancing awareness of the company’s business trends, growth perspectives, and more.

Key Highlights

Simulations Plus, Inc. is a publicly traded software and consulting company founded in 1996 in Lancaster, California. For over 30 years, the company has provided innovative solutions that support scientists and teams across the drug development lifecycle. It operates two primary business segments, Software and Services, delivering advanced modeling and simulation tools alongside expert consulting support from discovery to commercialization. The company has a strong global presence, with offices in Lancaster, California, Research Triangle Park, North Carolina, and Buffalo, New York, as well as international operations including Lixoft SAS in France. Its technology is utilized by over 280 clients worldwide, including 19 of the top 20 global pharmaceutical companies, regulatory agencies, biotechnology firms, and consumer goods companies. Simulations Plus’ software portfolio includes GastroPlus, ADMET Predictor, MonolixSuite, and DILIsym, enabling mechanistic modeling of absorption, pharmacokinetics, pharmacodynamics, AI-driven predictions, and quantitative systems pharmacology. Its Services segment provides expert consulting, training, and workshops to support all stages of drug discovery, development, clinical operations, and regulatory submission. With integrated AI-enabled workflows, Simulations Plus continues to improve the quality of life through science-driven, reliable, and innovative solutions.

Simulations Plus Inc. in the News:-

2026-05-22 – Simulations Plus to Participate in the 23rd Annual Craig
2026-05-06 – Simulations Plus and NVIDIA Collaborate to Scale GPU
2026-04-21 – Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products
2026-04-20 – Informed Drug Development Training Through Its 2026 Spring School
2025-07-15 – Simulations Plus Invests in Clinical Development Technology Company Nurocor

Scope

• Tactical Analysis:- Various strategic frameworks to gain insights into a Simulations Plus Inc.’s competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
• Business Strategy:- Contributes to shaping the Simulations Plus Inc.’s overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
• Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company’s future prospects. These components collectively contribute to understanding the financial health and market perception of the company.
• Company Fundamentals:- These fundamentals offer valuable insights into the company’s history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
• Competitive Landscape:- An identification of the Simulations Plus Inc.’s main competitors, providing insights into the competitive landscape it operates in.

Reasons to Buy

• Comprehensive Understanding of the Simulations Plus Inc.’s internal and external factors through SWOT analysis, Financial Analysis, and Competitors Benchmarking.
• Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
• Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
• Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
• Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation.
• Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.

Additionally, available deep-dive analysis on the company Simulations Plus Inc.:

• Simulations Plus Inc. PESTLE Analysis
• Simulations Plus Inc. Value Chain Analysis
• Simulations Plus Inc. Porter’s Five Forces Analysis
• Simulations Plus Inc. VRIO Analysis
• Simulations Plus Inc. BCG Analysis
• Simulations Plus Inc. Segmentation, Targeting and Positioning (STP) Analysis
• Simulations Plus Inc. Ansoff Matrix Analysis

Table of Contents

Table of Contents 2
Tables 5
Charts 6
Simulations Plus Inc. – Key Company Facts 7
Simulations Plus Inc. – Company Description 8
Simulations Plus Inc. – Top Executives 9
Simulations Plus Inc. – Head Office & Locations 11
Head Office – Country 11
Simulations Plus Inc. – Products and Services 12
Products 12
Services 13
Simulations Plus Inc. – Corporate Strategy 14
Simulations Plus Inc. – Business Description 19
Services Segment 19
Software Segment 20
Simulations Plus Inc. – ESG Spotlight 21
Environment 21
Social 22
Corporate Governance 22
Simulations Plus Inc. – SWOT Analysis 24
Overview 24
Strengths 26
Weaknesses 28
Opportunities 30
Threats 32
Simulations Plus Inc. – Financial Deep Dive 34
Share Price Trend – Jun-2025 to Jun-2026 (Average Share Closing Price) 34
Profit and Loss Statement 36
Summary of Profit and Loss Statement 36
Balance Sheet 40
Summary of Balance Sheet 40
Cash Flow Statement 44
Summary of Cash Flow Statement 44
Key Financial Ratio Analysis 48
Simulations Plus Inc. – Ratio Charts 50
Activity Ratio Charts 50
Growth Ratios Charts 51
Leverage Ratio Charts 55
Liquidity Ratio Charts 57
Profitability Ratio Charts 59
Competing Players 61
Snapshot of Competing Players 62
ICON Plc 62
Key Company Facts 62
Company Description 62
Key Financials 63
Share Price Trend – Jun-2025 to Jun-2026 (Average Share Closing Price) 63
Key Financial Ratio Analysis 68
Key Financials 70
Share Price Trend – Jun-2025 to Jun-2026 (Average Share Closing Price) 70
Key Financial Ratio Analysis 75
Veeva Systems Inc 77
Key Company Facts 77
Company Description 77
Key Financials 78
Share Price Trend – Jun-2025 to Jun-2026 (Average Share Closing Price) 78
Key Financial Ratio Analysis 83
Schrodinger, Inc 85
Key Company Facts 85
Company Description 85
Key Financials 86
Share Price Trend – Jun-2025 to Jun-2026 (Average Share Closing Price) 86
Key Financial Ratio Analysis 91
Key Financials 93
Share Price Trend – Jun-2025 to Jun-2026 (Average Share Closing Price) 93
Key Financial Ratio Analysis 98
Simulations Plus Inc. – In the News 100
15-Jul-2025 – Simulations Plus Invests in Clinical Development Technology Company Nurocor 100
12-Jun-2025 – Simulations Plus to Participate in the Citizens Medical Devices and Healthcare Services Forum 101
Appendix 102
Definitions 102
SWOT Analysis 102
PESTLE Analysis 102
Value Chain Analysis 102
ESG Spotlight 102
Financial Deep Dive 102
Financial Ratios 103
Activity Ratios 103
Growth Ratios 105
Leverage Ratios 108
Liquidity Ratios 110
Market Ratios 112
Profitability Ratios 114
Research Methodology 116
Disclaimer 117
Contact Us 117

List of Tables

Table 1: Simulations Plus Inc. – Company Facts 7
Table 2: Simulations Plus Inc. – Digital Presence 7
Table 3: Simulations Plus Inc. – Top Executives 9
Table 4: Simulations Plus Inc. – Products 12
Table 5: Simulations Plus Inc. – Services 13
Table 6: Simulations Plus Inc. – Share Price Trend – Jun-2025 to Jun-2026 34
Table 7: Simulations Plus Inc. – Profit and Loss Statement – 2022-2025 37
Table 8: Simulations Plus Inc. – Balance Sheet – 2022-2025 41
Table 9: Simulations Plus Inc. – Cash Flow Statement – 2022-2025 45
Table 10: Simulations Plus Inc. – Ratio Analysis – 2022-2025 48
Table 11: Simulations Plus Inc. – Competing Players 61
Table 12: Competing Players – ICON Plc – Key Company Facts 62
Table 13: ICON Plc – Share Price Trend – Jun-2025 to Jun-2026 63
Table 14: Competing Players – ICON Plc – Profit and Loss Statement – 2022-2025 65
Table 15: ICON Plc – Balance Sheet 2022-2025 66
Table 16: ICON Plc – Cash Flow Statement 2022-2025 67
Table 17: ICON Plc – Ratio Analysis – 2022-2025 68
Table 19: Physiomics Plc – Share Price Trend – Jun-2025 to Jun-2026 70
Table 20: Competing Players – Physiomics Plc – Profit and Loss Statement – 2021-2024 72
Table 21: Physiomics Plc – Balance Sheet 2021-2024 73
Table 22: Physiomics Plc – Cash Flow Statement 2021-2024 74
Table 23: Physiomics Plc – Ratio Analysis – 2021-2024 75
Table 24: Competing Players – Veeva Systems Inc – Key Company Facts 77
Table 25: Veeva Systems Inc – Share Price Trend – Jun-2025 to Jun-2026 78
Table 26: Competing Players – Veeva Systems Inc – Profit and Loss Statement – 2023-2026 80
Table 27: Veeva Systems Inc – Balance Sheet 2023-2026 81
Table 28: Veeva Systems Inc – Cash Flow Statement 2023-2026 82
Table 29: Veeva Systems Inc – Ratio Analysis – 2023-2026 83
Table 30: Competing Players – Schrodinger, Inc. – Key Company Facts 85
Table 31: Schrodinger, Inc. – Share Price Trend – Jun-2025 to Jun-2026 86
Table 32: Competing Players – Schrodinger, Inc. – Profit and Loss Statement – 2022-2025 88
Table 33: Schrodinger, Inc. – Balance Sheet 2022-2025 89
Table 34: Schrodinger, Inc. – Cash Flow Statement 2022-2025 90
Table 35: Schrodinger, Inc. – Ratio Analysis – 2022-2025 91
Table 37: Certara Inc – Share Price Trend – Jun-2025 to Jun-2026 93
Table 38: Competing Players – Certara Inc – Profit and Loss Statement – 2022-2025 95
Table 39: Certara Inc – Balance Sheet 2022-2025 96
Table 40: Certara Inc – Cash Flow Statement 2022-2025 97
Table 41: Certara Inc – Ratio Analysis – 2022-2025 98

List of Figures

Figure 1: Simulations Plus Inc. – SWOT Analysis 25
Figure 2: Simulations Plus Inc. – Average Share Price Trend – Jun-2025 to Jun-2026 35
Figure 3: Simulations Plus Inc. – Profit and Loss Statement – 2022-2025 39
Figure 4: Simulations Plus Inc. – Balance Sheet – 2022-2025 43
Figure 5: Simulations Plus Inc. – Cash Flow Statement 2022-2025 47
Figure 6: Simulations Plus Inc. – Activity Ratio Charts 50
Figure 7: Simulations Plus Inc. – Growth Ratio Charts (Value %) 51
Figure 8: Simulations Plus Inc. – Leverage Ratio Charts 55
Figure 9: Simulations Plus Inc. – Liquidity Ratio Charts 57
Figure 10: Simulations Plus Inc. – Profitability Ratio Charts (Value %) 59
Figure 11: ICON Plc – Average Share Price Trend – Jun-2025 to Jun-2026 64
Figure 12: ICON Plc – Profit and Loss Statement – 2022-2025 65
Figure 13: ICON Plc – Balance Sheet – 2022-2025 66
Figure 14: ICON Plc – Cash Flow Statement 2022-2025 67
Figure 15: Physiomics Plc – Average Share Price Trend – Jun-2025 to Jun-2026 71
Figure 16: Physiomics Plc – Profit and Loss Statement – 2021-2024 72
Figure 17: Physiomics Plc – Balance Sheet – 2021-2024 73
Figure 18: Physiomics Plc – Cash Flow Statement 2021-2024 74
Figure 19: Veeva Systems Inc – Average Share Price Trend – Jun-2025 to Jun-2026 79
Figure 20: Veeva Systems Inc – Profit and Loss Statement – 2023-2026 80
Figure 21: Veeva Systems Inc – Balance Sheet – 2023-2026 81
Figure 22: Veeva Systems Inc – Cash Flow Statement 2023-2026 82
Figure 23: Schrodinger, Inc. – Average Share Price Trend – Jun-2025 to Jun-2026 87
Figure 24: Schrodinger, Inc. – Profit and Loss Statement – 2022-2025 88
Figure 25: Schrodinger, Inc. – Balance Sheet – 2022-2025 89
Figure 26: Schrodinger, Inc. – Cash Flow Statement 2022-2025 90
Figure 27: Certara Inc – Average Share Price Trend – Jun-2025 to Jun-2026 94
Figure 28: Certara Inc – Profit and Loss Statement – 2022-2025 95
Figure 29: Certara Inc – Balance Sheet – 2022-2025 96
Figure 30: Certara Inc – Cash Flow Statement 2022-2025 97

---

---